YATHARTH logo

Yatharth Hospital & Trauma Care Services Limited Stock Price

NSEI:YATHARTH Community·₹77.9b Market Cap
  • 1 Narratives written by author
  • 0 Comments on narratives written by author
  • 27 Fair Values set on narratives written by author

YATHARTH Share Price Performance

₹808.75
216.85 (36.64%)
3.1% undervalued intrinsic discount
₹835.00
Fair Value
₹808.75
216.85 (36.64%)
3.1% undervalued intrinsic discount
₹835.00
Fair Value
Price ₹808.75
AnalystConsensusTarget ₹835.00

YATHARTH Community Narratives

AnalystConsensusTarget·
Fair Value ₹835 1.1% undervalued intrinsic discount

India's Urbanization And Demographics Will Drive Healthcare Expansion

0users have liked this narrative
0users have commented on this narrative
17users have followed this narrative

Recent YATHARTH News & Updates

Is Now An Opportune Moment To Examine Yatharth Hospital & Trauma Care Services Limited (NSE:YATHARTH)?

Sep 05
Is Now An Opportune Moment To Examine Yatharth Hospital & Trauma Care Services Limited (NSE:YATHARTH)?

Yatharth Hospital & Trauma Care Services Limited's (NSE:YATHARTH) 25% Price Boost Is Out Of Tune With Earnings

Jul 22
Yatharth Hospital & Trauma Care Services Limited's (NSE:YATHARTH) 25% Price Boost Is Out Of Tune With Earnings

Yatharth Hospital & Trauma Care Services' (NSE:YATHARTH) Solid Earnings May Rest On Weak Foundations

Jun 03
Yatharth Hospital & Trauma Care Services' (NSE:YATHARTH) Solid Earnings May Rest On Weak Foundations

Earnings Beat: Yatharth Hospital & Trauma Care Services Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

May 30
Earnings Beat: Yatharth Hospital & Trauma Care Services Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Yatharth Hospital & Trauma Care Services Limited Key Details

₹9.3b

Revenue

₹3.6b

Cost of Revenue

₹5.7b

Gross Profit

₹4.2b

Other Expenses

₹1.4b

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
Earnings per share (EPS)
14.76
Gross Margin
61.00%
Net Profit Margin
15.35%
Debt/Equity Ratio
0.7%

Yatharth Hospital & Trauma Care Services Limited Competitors

 
 
 
 
 
 
 
 
 
 
 
 

Snowflake Analysis

Flawless balance sheet with high growth potential.

0 Risks
2 Rewards

About YATHARTH

Founded
2008
Employees
4895
CEO
Amit Singh
WebsiteView website
www.yatharthhospitals.com

Yatharth Hospital & Trauma Care Services Limited, together with its subsidiaries, owns and operates super-specialty hospitals in India. The company offers services in the areas of medicine, cardiology, neurosciences, general surgery, nephrology and urology, pediatrics, gastroenterology, pulmonology, gynecology, orthopedics, spine and rheumatology, plastic and cosmetic surgery, ear, nose, throat, endocrinology, critical care, dermatology, nuclear medicine, and cancer and bone marrow transplant. It also provides services in the areas of GI surgery and liver transplant, robotic surgery, kidney transplant, IVF and fertility, emergency medicine, ophthalmology, dentistry, psychology and psychiatry, physiotherapy and rehabilitation, anesthesiology, radiology, pathology and laboratory medicine, nutrition and health, interventional spine and pain medicine, neurology, neurosurgery, and cardiovascular and thoracic surgery. In addition, the company sells medicines and canteen food. The company was incorporated in 2008 and is based in Noida, India.

Market Insight

Q4 2025 is off to a flying start with record highs being printed left, right, and center. US and Japanese stocks made fresh new highs, while the gold price powered through $4,000 for the first time, and Bitcoin crossed the $126k level. Is this all a case of USD weakness, irrational exuberance, or solid fundamentals? This week, we are reviewing Q3 market performance, Q2 earnings season, and the outlook heading into the end of 2025…
Continue reading

Indian Market Performance

  • 7 Days: 1.1%
  • 3 Months: -0.1%
  • 1 Year: -4.4%
  • Year to Date: 1.3%
The market is up 1.1% over the last week, with the Information Technology sector leading the way, up 4.3%. In contrast, the market has seen a decline of 4.4% over the last 12 months. Looking forward, earnings are forecast to grow by 16% annually. Market details ›